TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice

Nature Medicine
Tony Wyss-CorayL Mucke

Abstract

Abnormal accumulation of the amyloid-beta peptide (Abeta) in the brain appears crucial to pathogenesis in all forms of Alzheimer disease (AD), but the underlying mechanisms in the sporadic forms of AD remain unknown. Transforming growth factor beta1 (TGF-beta1), a key regulator of the brain's responses to injury and inflammation, has been implicated in Abeta deposition in vivo. Here we demonstrate that a modest increase in astroglial TGF-beta1 production in aged transgenic mice expressing the human beta-amyloid precursor protein (hAPP) results in a three-fold reduction in the number of parenchymal amyloid plaques, a 50% reduction in the overall Abeta load in the hippocampus and neocortex, and a decrease in the number of dystrophic neurites. In mice expressing hAPP and TGF-beta1, Abeta accumulated substantially in cerebral blood vessels, but not in parenchymal plaques. In human cases of AD, Abeta immunoreactivity associated with parenchymal plaques was inversely correlated with Abeta in blood vessels and cortical TGF-beta1 mRNA levels. The reduction of parenchymal plaques in hAPP/TGF-beta1 mice was associated with a strong activation of microglia and an increase in inflammatory mediators. Recombinant TGF-beta1 stimulated Abeta c...Continue Reading

References

Mar 1, 1992·Journal of Clinical Immunology·S M Wahl
Sep 1, 1990·Journal of Neuroscience Research·J YaoC A Colton
May 1, 1995·Journal of Neuropathology and Experimental Neurology·E GalbreathA Messing
Aug 1, 1994·Molecular Neurobiology·R Kisilevsky
Dec 1, 1993·Journal of Cellular Biochemistry·C E FinchG M Pasinetti
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·K Johnson-WoodL McConlogue
May 1, 1997·Kidney International·W A Border, N A Noble
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Sturchler-PierratB Sommer
Feb 14, 1998·Progress in Neurobiology·K C FlandersC F Lippa
Nov 26, 1998·The Journal of Biological Chemistry·W Q QiuD J Selkoe
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·A Y HsiaL Mucke
Mar 17, 1999·The Journal of Clinical Investigation·D M HoltzmanS M Paul
Apr 16, 1999·Journal of Leukocyte Biology·P L McGeer, E G McGeer
Jun 12, 1999·American Journal of Human Genetics·D Giulian
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·M E CalhounM Jucker
Apr 4, 2000·Neurology·Z GuoL A Farrer
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray

❮ Previous
Next ❯

Citations

Jun 20, 2012·Archivum Immunologiae Et Therapiae Experimentalis·Megan M Varnum, Tsuneya Ikezu
Sep 19, 2009·Seminars in Immunopathology·Lisa Walter, Harald Neumann
Nov 27, 2007·Acta Neuropathologica·Charles DuyckaertsBenoît Delatour
Aug 19, 2011·Cell and Tissue Research·Kristina Beck, Christian Schachtrup
Sep 1, 2011·Cell and Tissue Research·Filippo CaraciAgata Copani
Feb 15, 2012·Cell and Tissue Research·Bettina LinnartzHarald Neumann
Apr 25, 2012·Purinergic Signalling·Gary A WeismanLaurie Erb
May 25, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Melvin K SimmonsMichael C Montalto
Aug 12, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Kavon Rezai-ZadehTerrence Town
Jun 19, 2013·CNS Drugs·Mercé FalipCarlos Cara
Mar 1, 1960·Clinica Chimica Acta; International Journal of Clinical Chemistry·J REJNEK, T BEDNARIK
Dec 20, 2002·Nature·Howard L Weiner, Dennis J Selkoe
Sep 3, 2002·Nature Medicine·Todd E Golde
Jun 3, 2008·Nature Medicine·Terrence TownRichard A Flavell
Jul 28, 2012·Nature Neuroscience·Shalina S Ousman, Paul Kubes
Nov 28, 2006·Nature Neuroscience·Helmut Kettenmann
Apr 28, 2006·Nature Reviews. Immunology·Howard L Weiner, Dan Frenkel
Jul 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tony Wyss-CorayEliezer Masliah
May 23, 2007·The Journal of Experimental Medicine·Kuen-Jer TsaiChe-Kun James Shen
Oct 15, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Paramita ChakrabartyPritam Das
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Tony Wyss-Coray, Joseph Rogers
Sep 12, 2006·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Lucia MalaguarneraMariano Malaguarnera
Apr 7, 2005·Genes, Brain, and Behavior·A Stéphan, A G Phillips
Apr 19, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·T HamaguchiM Yamada
Mar 29, 2012·Current Gerontology and Geriatrics Research·Donna M Wilcock
Jul 31, 2012·International Journal of Alzheimer's Disease·Donna M Wilcock
Jun 24, 2004·Dementia and Geriatric Cognitive Disorders·Mattias HaglundElisabet Englund
Jan 23, 2010·Dementia and Geriatric Cognitive Disorders·Shuang-Qing ChenFeng-Chao Zang
Aug 5, 2003·The Journal of Clinical Investigation·Alon MonsonegoHoward L Weiner
Nov 3, 2006·The Journal of Clinical Investigation·Ina TesseurTony Wyss-Coray
Nov 3, 2006·The Journal of Clinical Investigation·Pritam Das, Todd Golde
Jun 6, 2007·The Journal of Clinical Investigation·Solomon S ShaftelM Kerry O'Banion
Jun 6, 2007·The Journal of Clinical Investigation·Cynthia A Lemere
Nov 5, 2008·The Journal of Clinical Investigation·Lawrence Steinman
Nov 5, 2008·The Journal of Clinical Investigation·Marc Feldmann
Apr 3, 2012·The Journal of Clinical Investigation·Eva Czirr, Tony Wyss-Coray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.